NWBO News and Press, Northwest Biotherapeutics Inc. From 10/13/23

Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application PR Newswire BETHESDA, Md. , Oct. 13, 2023 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCV...

LAS VEGAS, NV / ACCESSWIRE / September 25, 2023 / Crown Equity Holdings, Inc. (OTC PINK:CRWE) today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a proposed public offering of its common stock. The public offering is ...

Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory Board PR Newswire BETHESDA, Md. , Sept. 12, 2023 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax &#...

Northwest Biotherapeutics Announces Completion of Prerequisites, and Plans for Submission of Marketing Authorization Application PR Newswire BETHESDA, Md. , Aug. 29, 2023 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company ...

2023-08-17 16:56:25 ET Summary Northwest Biotherapeutics is a biotech focused on developing a dendritic cell vaccine to fight cancer. The company has faced financial challenges and has relied on dilution to raise funds. While they have achieved success in glioblastoma, funding...

2023-04-30 04:06:29 ET Summary NWBO continues to slog away, with no definite date of a BLA submission. They recently made provisions for a large dilution, took a "toxic" loan, and got a manufacturing approval in the UK. There's progress, but it is agonizingly slow, and the sto...

2023-03-21 06:51:52 ET Northwest Biotherapeutics ( OTCQB:NWBO ) and Advent BioServices said that the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) approved and issued a MIA license to commercially manufacture cell therapy products at the GMP facility in Sa...

Northwest Biotherapeutics and Advent BioServices Announce Receipt of License for Commercial Manufacturing at Sawston, U.K. Facility PR Newswire One of the First UK Licenses for Commercial Manufacturing of Cell Therapy Products; Allows Global Delivery of the Products ...

Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB PR Newswire BETHESDA, Md. , March 11, 2023 /PRNewswire/ --  Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax ® personalized ...

2023-03-09 06:49:58 ET Cancer-focused biotech Northwest Biotherapeutics ( OTCQB:NWBO ) has entered into a loan agreement worth more than $11.0M with Utah-based Streeterville Capital LLC. Per the terms, the deal has a maturity of 22 months, and debt repayments will begin from N...